Welcome to ECVERY
The microcomputer control liquid crystal display drugs melting point apparatus
The microcomputer control liquid crystal display drugs melting point apparatus
Supplier Info
[China Supplier]
Contact Person : Ms. li yang
Tel : 86-392-3311689,13803929686
Fax : 86-392-33152622
Product Detail
melting point apparatus reliable work,high precision temperature control,measuring,accuracy,good reproducibility,simple operate

Instrument Model: APEX-LJ788 drug melting point apparatus Description:

APEX-LJ788 drug melting point apparatus using pharmacopoeia prescribed capillary as sample tube and liquid transfer temperature way, USES the microcomputer control temperature programmed, reliable work, high precision temperature control, measurement accuracy, good reproducibility, simple operation, in line with the pharmacopoeia of the People's Republic of China on melting point determination method in instrument equipment and methods for determining the regulations and requirements, also accord with the us, the UK, Japan and other countries for melting point determination of pharmacopoeia requirements, used in medicine, chemical reagent, spices, dye and other industry production and scientific research, the measuring organic crystal material melting point.

Applications: Melting point apparatus according to an important position in the chemical industry, medicine and research, it is an essential instrument for the production of drugs, perfumes, dyes and other organic crystal substances.

Main specification:

Melting point rangeroom temperature -270 °C
Heating rate0.5 °C / min, 1.0 ° C / min, 1.5 °C / min, 3.0 °C / min, fourth gear (For other rate can book)
Rate deviation<5% 
Measurement accuracy<200 ° C is not greater than ± 0.5 ° C> 200 ° C is not greater than ± 1.0 °C 
Temperature presets room temperature -260 °C within any preset 
The temperature mediummethyl silicone oil 
The stable liquid cup: 250ml beaker
Ambient temperature20 °C ± 10 °C
Power supply220V ± 10%, 50Hz <200W 

Performance characteristics 1, real-time temperature record the value of the two melting and early melting point, the melting point of the final record key. 2, according to the provisions of the Pharmacopoeia melting point determination, the samples should be in the liquid temperature below its melting point of about 10 °C placed pass temperature liquid, and then the rate constant temperature until the sample melted, with the temperature preset function Pharmacopoeia requirements. 3, have been recorded under the preset value, the next time you turn on the preset temperature is the preset value. 4, after the preset temperature is reached, the time delay of about 1 minute, so that the liquid in a stable temperature state, the buzzer. 5, when the sample is melted early melting, and finally melting key to record the beginning of the melting point, the end of the melting point of the value. 6, there are three operating states: the reset state, the state of readiness test status. 7, the beginning of the melting point of the key, and finally melting point key can also be used to measure the melting point of the two samples, the melting point of a sample of the early melting point record value Final melting point of the record another sample melting point value.

Friendly Tips:

We guarantee the product description is true and effective. After installation, for your safety, please use the instruments with ground connection .In the first year of your using the product, we replace the damaged parts.(Except consumables )

 With decades of experience, we can provide a wide range of professional laboratory solutions. Please contact us if you can not find your desired lab equipments on our website. We will help you to find manufactures who can guarantee the quality.

The microcomputer control liquid crystal display drugs melting point apparatus

Ads by Google

About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.